About Rapiddx Technologies
Rapiddx Technologies is a company based in Bengaluru (India) founded in 2019 by Satish Kalme. Rapiddx Technologies offers products and services including rPASAâ„¢ Platform and Microfluidics Chip. Rapiddx Technologies operates in a competitive market with competitors including Cepheid, Day Zero Diagnostics, SeLux Diagnostics, Rapid Micro Biosystems and SpinDiag, among others.
- Headquarter Bengaluru, India
- Founders Satish Kalme
- SectorsHealthcare
- Email••••••••
- Website rapiddxtech.com
- Social LinkedIn
- Legal Name Rapiddx Technologies Private Limited
- Date of Incorporation 12 Jun, 2019
- Jurisdiction Bengaluru, Karnataka, India
- Net Loss-₹4.5 Lakh
FY 2023 · 0% margin
- EBITDA-₹3.5 Lakh
FY 2023 · 0% margin
- Investors
Associated legal entities of Rapiddx Technologies
Rapiddx Technologies operates through Rapiddx Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rapiddx Technologies Private Limited CIN U33110KA2019PTC125162 | Active | 12 Jun 2019 | Bengaluru, Karnataka | – | – | 2 | View details |
Products & Services of Rapiddx Technologies
Rapiddx Technologies offers a comprehensive portfolio of products and services, including rPASA™ Platform and Microfluidics Chip.
Rapid tests antimicrobial susceptibility from clinical samples.
Enables efficient, affordable pathogen analysis in healthcare settings.
Funding Insights of Rapiddx Technologies
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Rapiddx Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Rapiddx Technologies
Rapiddx Technologies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include C-CAMP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bioscience research, innovation, and entrepreneurship facilitation in life sciences are conducted in India. | 2010 | ccamp.res.in | Bengaluru, India |
Investor details for Rapiddx Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Rapiddx Technologies Private Limited (Rapiddx Technologies)
Rapiddx Technologies Private Limited is the primary company behind Rapiddx Technologies. The board of Rapiddx Technologies Private Limited currently have 2 directors; the longest-serving is Satish Dnyanoba Kalme, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Satish Dnyanoba Kalme DIN 07878983 | Director | 12 Jun 2019 | 7 yrs 3 mo | Rapiddx Technologies Private Limited |
| Taslimarif Turabmiya Saiyed DIN 06757317 | Director | 12 Jun 2019 | 7 yrs 3 mo | Rapiddx Technologies Private Limited |
People of Rapiddx Technologies
1 people are tracked at Rapiddx Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Rapiddx Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Rapiddx Technologies
Figures of Rapiddx Technologies Private Limited, the primary company behind Rapiddx Technologies, for FY 2023. Net loss was -₹4.5 Lakh (0% margin). EBITDA was -₹3.5 Lakh (0% margin).
- -₹4.5 LakhNet loss · 0% margin
- -₹3.5 LakhEBITDA · 0% margin
- ₹2 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Rapiddx Technologies Private Limited are on its company page.
Detailed financial statements for Rapiddx Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Rapiddx Technologies
2 dated milestones of Rapiddx Technologies across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Rapiddx Technologies is founded.
- Funding First funding round.
Competitors of Rapiddx Technologies
Rapiddx Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Day Zero Diagnostics, SeLux Diagnostics, Rapid Micro Biosystems and SpinDiag, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| seluxdx.com | 2014 | Cambridge, United States | $161.01M | – | Developer of alternatives to traditional ELISA assays | |
| rapidmicrobio.com | 2006 | Bedford, United Kingdom | $349.7M | 202 | Biosystems for microbial contamination detection are developed and supplied. | |
| spindiag.de | 2016 | – | $27.69M | – | Point-of-care systems for screening drug-resistant pathogens are developed. | |
| specificdx.com | 2009 | San Francisco, United States | $30M | – | Detection and antibiotic susceptibility testing for blood infections are provided. | |
| microbedx.com | 2015 | Los Angeles, United States | $6.21M | – | Provider of the solutions for the detection of antibiotic susceptibility in urinary tract infections | |
| insilixa.com | 2012 | Sunnyvale, United States | $13M | 40 | Develops innovative point-of-care diagnostics using semiconductor-based CMOS biochip technology. |
Detailed competitors of Rapiddx Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Rapiddx Technologies
10 companies that operate in the same segment as Rapiddx Technologies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rapiddx Technologies
Rapiddx Technologies was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Rapiddx Technologies is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Rapiddx Technologies was established in 2019 in Bengaluru, India, within the health diagnostics sector. An antimicrobial susceptibility testing platform is created by the company, employing patented sensor technology. Susceptibility is assessed directly from clinical samples using a microfluidics-based system. Operations focus on rapid diagnostic solutions for antimicrobial resistance, supporting clinical applications in healthcare settings across India.
Rapiddx Technologies's top competitors include Cepheid, Rapid Micro Biosystems and Day Zero Diagnostics.
Rapiddx Technologies offers rPASAâ„¢ Platform and Microfluidics Chip.
Rapiddx Technologies has 1 investor. Key investors include C-CAMP.
Rapiddx Technologies operates through Rapiddx Technologies Private Limited.
The legal entities of Rapiddx Technologies currently have 2 directors, including Satish Dnyanoba Kalme, Taslimarif Turabmiya Saiyed.